Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Consortium for Organ Preservation in Europe (COPE) – an EU funded surgical research project on organ preservation – is running three clinical trials in five European countries. As of December 2014, all COPE trials are now live.

COPE is an EU-wide research network of Universities, Research Institutions and Small and Medium Sized Enterprises (SMEs) carrying out clinical trials and experimental work programs in liver and kidney transplantation. COPE is running until June 2017 and is funded through the EU’s 7th framework program for research, technological development and demonstration.

COPE is running three clinical trials and the consortium is happy to announce that all three are now live.

For more details refer to the COPE website

 

Similar stories

Study finds previously unidentified genetic determinants of rare disease

A landmark study involving Oxford researchers, including Dr Sarah Howles from the Nuffield Department of Surgical Sciences, has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.